Healthcare: Perrigo Purchases Rosemont Pharmaceuticals for $283M
Perrigos second deal this month expands its liquid medications portfolio
Allegan, Mich.-based pharmaceutical company Perrigo Co. (Nasdaq: PRGO) is buying Rosemont Pharmaceuticals Ltd. for about $283 million.
Rosemont, based in Leeds, U.K., makes specialty and generic prescription pharmaceutical company that makes oral, liquid products.
The deal will broaden Perrigo’s consumer product portfolio, and aligns with its goal of adding more liquid medications its offerings and expanding its U.K. portfolio.
For more information on related topics, visit the following: